Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study

Peisen, Felix; Gerken, Annika; Hering, Alessa; Dahm, Isabel; Nikolaou, Konstantin; Gatidis, Sergios; Eigentler, Thomas K.; Amaral, Teresa; Moltz, Jan H.; Othman, Ahmed E.

dc.contributor.author	Peisen, Felix
dc.contributor.author	Dahm, Isabel
dc.contributor.author	Nikolaou, Konstantin
dc.contributor.author	Gatidis, Sergios
dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Amaral, Teresa
dc.contributor.author	Othman, Ahmed
dc.date.accessioned	2024-07-11T07:32:51Z
dc.date.available	2024-07-11T07:32:51Z
dc.date.issued	2023
dc.identifier.issn	2075-4418
dc.identifier.uri	http://hdl.handle.net/10900/154917
dc.language.iso	en	en
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/diagnostics13203210
dc.subject.ddc	610	de_DE
dc.title	Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_01010
utue.personen.roh	Peisen, Felix
utue.personen.roh	Gerken, Annika
utue.personen.roh	Hering, Alessa
utue.personen.roh	Dahm, Isabel
utue.personen.roh	Nikolaou, Konstantin
utue.personen.roh	Gatidis, Sergios
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Moltz, Jan H.
utue.personen.roh	Othman, Ahmed E.
dcterms.isPartOf.ZSTitelID	Diagnostics	de_DE
dcterms.isPartOf.ZS-Issue	20	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige